PegBio Co., Ltd. Schedules Board Meeting to Approve 2025 Annual Results

PegBio Co., Ltd. (Stock Code: 2565), a joint stock company incorporated in the People’s Republic of China with limited liability, has announced that its Board of Directors will convene a meeting on Monday, March 23, 2026. The primary agenda of this meeting is to consider and approve the annual results of the Group for the year ended December 31, 2025, and facilitate their publication.

Key Points for Investors and Shareholders

• Board Meeting Date: March 23, 2026
• Purpose: Approval and publication of PegBio’s annual financial results for 2025
• Other Business: The Board may also transact additional business matters during the meeting
• Potential Price Sensitivity: The annual results announcement is a significant event that could impact PegBio’s share price, as it will provide investors and the market with updated information on the company’s financial performance for the year

Board Composition

As of the announcement date, PegBio’s board is comprised of nine directors:

• Executive Directors: Dr. Michael Min XU (Chairman, Executive Director, and General Manager), Ms. Xiaojun WANG
• Non-Executive Directors: Dr. Xiangjun ZHOU, Dr. Yuhong XU, Ms. Ting ZHAI, Mr. Hongkai LI
• Independent Non-Executive Directors: Dr. Jiancun ZHANG, Dr. Yangyang CHEN, Ms. Xinpeng FAN

Implications for Shareholders

The scheduled Board meeting and subsequent annual results announcement are events that can influence PegBio’s share value. Investors and shareholders should closely monitor this development, as the company’s financial performance, outlook, and any additional business transacted at the meeting may have a direct impact on market sentiment and price movements.

It is important for shareholders to be aware that the Board may discuss matters beyond the annual results, which could include strategic decisions, operational updates, or other business items relevant to the Group’s ongoing activities and future prospects.

Recommendation

Investors are advised to stay informed and review the forthcoming annual results publication for insights into PegBio’s growth, profitability, and any management commentary on future plans. Material disclosures or unexpected changes in financial performance could provide important signals for trading and investment decisions.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult their financial advisors and review official company disclosures before making any investment decisions. The information presented is based on the latest company announcement and may be subject to change.

View PEGBIO CO-B Historical chart here